language_icon
EN
HI

Fortis Healthcare Share price

FORTIS

953.1

3.80 (-0.40%)
NSE
BSE
Last updated on 7 May, 2026 | 14:13 IST
Today's High

963.30

Today's Low

948.60

52 Week Low

646.70

52 Week High

1104.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Fortis Healthcare Chart

Fortis Healthcare Share Key Metrics

Volume
4.51 L
Market Cap
72241.95 CR
LTQ@LTP
1@953.10
ATP
953.26
Var Margin
15.17 %
Circuit Range
861.25-1052.55
Delivery %
52.68 %
Value
42.97 CR
ASM/GSM
No
Market Lot
1

Summary

Fortis Healthcare share price stands at ₹953.1 at 7 May, 2026 | 14:13. The stock Fortis Healthcare intraday movement has stayed between ₹948.60 and ₹963.30, while on a 52-week basis it has fluctuated from ₹646.70 to ₹1104.30.
In terms of trading activity, Fortis Healthcare has recorded a volume of 450790 shares. The Fortis Healthcare has a market cap of ₹754958148. The stock’s Average Traded Price (ATP) stands at ₹95326, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 95310.
The Fortis Healthcare operates within a circuit range of ₹861.25-1052.55 – ₹861.25-1052.55, with a Value of ₹42.97 CR. The Delivery Percentage for the day is 52.68%. Additionally, Fortis Healthcare currently falls under the No framework, and trades with a market lot size of 1.

Fortis Healthcare Fundamentals

View More
P/E Ratio

74.68

P/B Ratio

7.45

Div. Yield

0.11

Sector P/E

55.28

Sector P/B

-15.97

Sec. Div. Yield

1.88

Fortis Healthcare Resistance and Support

Pivot 952.67

Resistance

First Resistance

964.34

Second Resistance

971.77

Third Resistance

983.44

Support

First Support

945.24

Second Support

933.57

Third Support

926.14

Fortis Healthcare Futures & Options

link_white_icon

Fortis Healthcare Option Chain

View Price, OI, Greeks & More...
View All

26MAY26

955.65

-8.60 (0.89%)

30JUN26

960.65

-9.50 (0.98%)

28JUL26

961.30

-11.80 (1.21%)

FORTIS|26MAY26 CE 950.00

28.50

-4.9 (-14.67%)

FORTIS|26MAY26 PE 960.00

27.2

3.3 (13.81%)

Fortis Healthcare Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

31.17%

Mutual Fund

25.72%

Insurance

3.88%

Foreign Institutional Investors

25.98%

Domestic Institutional Investors

1.74%

Retail

11.51%

Others

0%

Total Promoters
MAR '26
31.17%

Fortis Healthcare Corporate Actions

DateAgenda
2026-02-13Quarterly Results
2025-11-11Quarterly Results
2025-08-06Quarterly Results & Others
2025-05-20Audited Results & Final Dividend
2025-02-07Quarterly Results

Fortis Healthcare News

Fortis Healthcare Limited

Fortis Healthcare announced that the Tokyo District Court has concluded preparatory and oral proceedings for the material litigation between Northern TK Venture Pte Ltd and Daiichi Sankyo. The judgment for this case is scheduled to be announced on September 10, 2026.
Apr 29 2026 13:04:00

Fortis Healthcare Ltd - 532843 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations') Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan.

Fortis Healthcare announced the conclusion of preparatory and oral proceedings for its material litigation with Northern TK Venture against Daiichi Sankyo in the Tokyo District Court. The judgment for this significant case is now scheduled to be announced on September 10, 2026.
Apr 29 2026 13:04:00

Stocks to buy in 2026 for long term: PNB Housing, Fortis Healthcare among 5 stocks that could give 10-20% return

Brokerages have identified Fortis Healthcare among five stocks with potential for 10-20% returns for long-term investors in 2026, citing selective optimism across healthcare and other key sectors despite market volatility.
Apr 27 2026 07:04:00

Fortis Healthcare Limited

Fortis Healthcare will host an investor/analyst non-deal roadshow on April 27-28, 2026, in Mumbai. The meeting will involve one-on-one and group discussions on the company's general business update and industry outlook.
Apr 22 2026 17:04:00

Fortis Healthcare Limited

Fortis Healthcare will host an investor/analyst non-deal roadshow on April 27-28, 2026, in Mumbai. The meeting will involve one-on-one and group discussions on the company's general business update and industry outlook.
Apr 22 2026 17:04:00

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Fortis Healthcare will host investor and analyst meetings on April 27-28, 2026. These meetings in Mumbai will cover general business updates and industry discussions.
Apr 22 2026 16:04:00

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Fortis Healthcare will host investor and analyst meetings on April 27-28, 2026. These meetings in Mumbai will cover general business updates and industry discussions.
Apr 22 2026 16:04:00

Fortis Healthcare Limited

Fortis Healthcare disclosed details of non-convertible securities and commercial paper for FY26 as per SEBI Master Circular. This includes listing data for three issues totaling ₹1550 crores and current Stable AA+ credit ratings from CRISIL.
Apr 10 2026 12:04:00

Fortis Healthcare Ltd - 532843 - Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated October 15, 2025.

Fortis Healthcare disclosed comprehensive details of non-convertible securities and commercial paper totaling ₹1550 crore for the financial year ended March 31, 2026. This filing ensures compliance with the SEBI Master Circular, enhancing transparency on its debt instruments and their credit ratings.
Apr 10 2026 12:04:00

Fortis Healthcare Limited

Fortis Healthcare reported details of ₹1,550 crore debt securities issued through private placement. These securities bear a 7.7648% annual coupon for the first year, with an issuance date of December 19, 2024, and maturity in December 2029.
Apr 08 2026 18:04:00
Read More

About Fortis Healthcare

NSE : 14592  
BSE : 532843  
ISIN : INE061F01013  

The Company was incorporated on February 28 1996 as Rancare Limited under the Companies Act. Subsequently on June 20 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1 1996.Changes in Registered Office:The registered office of the Company was initially situated at 25 Nehru Place New Delhi 110 019 India. Pursuant to a Board resolution dated September 16 2003 the registered office was shifted to B- 9 Maharani Bagh New Delhi 110 065 India. Subsequently pursuant to Board resolution dated February 10 2006 the registered office of the Company was shifted to Piccadily House 275- 276 4th Floor Captain Gaur Marg Srinivas Puri New Delhi 110 065 India which is the current RegisteredOffice.Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7 2005:The High Court of Delhi through its order dated October 7 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited (?FMCHL?) and which at the time of amalgamation was our board controlled subsidiary with effect from April 1 2004(?Scheme?).Salient features of the Scheme:The principal terms of the Scheme as sanctioned by the High Court of Delhi are set forth below: The entire undertaking and business all properties tangible and intangible assets including trademarks patents design copyrights investments approvals licenses tax benefits pending projects debts liabilities and obligations including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1 2004. Pursuant to the Scheme Fortis Hospital Amritsar was transferred to the Company. However the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL.All the staff workmen and employees of FMCHL in employment on the date immediately preceding December 23 2005 (i.e. the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL.In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL in the ratio of 1:4 (i.e. one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each).In compliance with the Scheme the Company allotted 520000 Equity Shares to the shareholders of erstwhile FMCHL on February 10 2006.Major Events:Year EventJune 2001 Commissioning of Fortis Hospital Mohali.August 2003 Inauguration and commissioning of Fortis Hospital Amritsar.October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital New Delhi.August 200 Commissioning of Fortis Hospital Noida.September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL EHSSIL EHSSHL and EHRCL.October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital New Delhi.January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme New Delhi and acquisition of 5% equity interest in Sunrise Medicare Private Limited with an option to acquire additional equity shares.January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute Srinagar.March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital Noida.March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited.

Read More

Fortis Healthcare Management

NamePosition
Satyendra ChauhanCompany Secretary & Compliance Officer
Leo PuriChairman
View More

Fortis Healthcare FAQs

The Buying Price of Fortis Healthcare share is 953.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Fortis Healthcare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fortis Healthcare, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Fortis Healthcare shares is 74.68. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Fortis Healthcare shares is 7.45. Useful to assess the stock's value relative to its book value.

To assess Fortis Healthcare’s valuation compare Sector P/E, P/B which are 55.28 & -15.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Fortis Healthcare is 72241.95 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Fortis Healthcare share price is 1104.30 & 646.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Fortis Healthcare belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost